Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial (GRAFFITI)
Graft Patency After FFR-guided Versus Angio-guided CABG: a Prospective, Multicenter, Multinational, Randomized (1:1) Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Contact
Study Contact
- Name: Emanuele Barbato, MD, PhD
- Email: emanuele.barbato@olvz-aalst.be
Study Locations
-
-
-
Aalst, Belgium, 9300
- Recruiting
- Cardiovascular Center Aalst OLV Hospital
-
Principal Investigator:
- Gabor Toth, MD
-
Principal Investigator:
- Emanuele Barbato, MD, PhD
-
Principal Investigator:
- Bernard De Bruyne, MD, PhD
-
-
-
-
-
Brno, Czech Republic
- Not yet recruiting
- Department of Internal Medicine and Cardiology, University Hospital Brno
-
Contact:
- Petr Kala, MD
- Email: kalapetr7@gmail.com
-
Principal Investigator:
- Petr Kala, MD
-
-
-
-
-
Budapest, Hungary
- Not yet recruiting
- Hungarian Institute of Cardiology
-
Contact:
- Zsolt Piroth
- Email: piroth@freemail.hu
-
Principal Investigator:
- Zsolt Piroth, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with stable angina, unstable angina or NSTEMI candidate to CABG
- Significant LAD and/or LM lesion - proved by FFR or Angiography AND
- At least one more, angiographycally intermediate lesion
Exclusion Criteria:
- Significant valvular disease with indication to surgical replacement
- Severe left ventricular dysfunction (EF<35%)
- Acute STEMI
- Atrial fibrillation, if Maze procedure is planned
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Angio-guided arm
In this arm will be included the patient randomized to a Angiography-guided surgical revascularization strategy.
|
The final intervention (surgical revascularization) will be the same for both arms.
|
|
Experimental: FFR-guided arm
In this arm will be included the patient randomized to a FFR-guided surgical revascularization strategy.
|
The final intervention (surgical revascularization) will be the same for both arms.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rate of occluded bypass grafts
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
a) Lenght of hospital stay; b) Changes in surgical strategy: i.e. open-chest surgery vs. mini-thoracotomy; extensive surgery versus minimal invasive approaches.
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 3-4 weeks
|
participants will be followed for the duration of hospital stay, an expected average of 3-4 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Emanuele Barbato, MD, PhD, Cardiovascular Center Aalst, OLV Hospital, Aalst (Belgium)
Publications and helpful links
General Publications
- Toth GG, De Bruyne B, Kala P, Ribichini FL, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial. EuroIntervention. 2019 Dec 6;15(11):e999-e1005. doi: 10.4244/EIJ-D-19-00463.
- Toth GG, De Bruyne B, Kala P, Ribichini FL, Casselman F, Ramos R, Piroth Z, Fournier S, Van Mieghem C, Penicka M, Mates M, Van Praet F, Degriek I, Barbato E. Study Design of the Graft Patency After FFR-Guided Versus Angiography-Guided CABG Trial (GRAFFITI). J Cardiovasc Transl Res. 2018 Aug;11(4):269-273. doi: 10.1007/s12265-018-9818-9. Epub 2018 Jul 19.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- GRAFFITI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.